106 related articles for article (PubMed ID: 2867641)
21. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
22. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
Kunz J
Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
[TBL] [Abstract][Full Text] [Related]
23. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
Friedman E; Thor A; Hand PH; Schlom J
Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
[TBL] [Abstract][Full Text] [Related]
24. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
Ethier SP; Mahacek ML; Gullick WJ; Frank TS; Weber BL
Cancer Res; 1993 Feb; 53(3):627-35. PubMed ID: 8425198
[TBL] [Abstract][Full Text] [Related]
25. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
[TBL] [Abstract][Full Text] [Related]
26. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas.
Ceriani RL; Peterson JA; Blank EW
Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions.
Bier B; Douglas-Jones A; Tötsch M; Dockhorn-Dworniczak B; Böcker W; Jasani B; Schmid KW
Breast Cancer Res Treat; 1994; 30(3):213-21. PubMed ID: 7981441
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
Berry N; Jones DB; Smallwood J; Taylor I; Kirkham N; Taylor-Papadimitriou J
Br J Cancer; 1985 Feb; 51(2):179-86. PubMed ID: 2578285
[TBL] [Abstract][Full Text] [Related]
29. Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study.
Croce MV; Colussi AG; Price MR; Segal-Eiras A
Anticancer Res; 1997; 17(6D):4287-92. PubMed ID: 9494522
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.
Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
World J Surg Oncol; 2015 Nov; 13():323. PubMed ID: 26607846
[TBL] [Abstract][Full Text] [Related]
31. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components.
Ceriani RL; Blank EW; Peterson JA
Cancer Res; 1987 Jan; 47(2):532-40. PubMed ID: 3791239
[TBL] [Abstract][Full Text] [Related]
32. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
33. Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium.
Petersen OW; van Deurs B; Nielsen KV; Madsen MW; Laursen I; Balslev I; Briand P
Cancer Res; 1990 Feb; 50(4):1257-70. PubMed ID: 2153455
[TBL] [Abstract][Full Text] [Related]
34. Fibronectin: a discrimination marker between small invasive carcinomas and benign proliferative lesions of the breast.
Christensen L
APMIS; 1990 Jul; 98(7):615-23. PubMed ID: 2397113
[TBL] [Abstract][Full Text] [Related]
35. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.
Briand P; Petersen OW; Van Deurs B
In Vitro Cell Dev Biol; 1987 Mar; 23(3):181-8. PubMed ID: 3558253
[TBL] [Abstract][Full Text] [Related]
36. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of the breast arising in microglandular adenosis.
James BA; Cranor ML; Rosen PP
Am J Clin Pathol; 1993 Nov; 100(5):507-13. PubMed ID: 7504394
[TBL] [Abstract][Full Text] [Related]
38. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
[TBL] [Abstract][Full Text] [Related]
39. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
40. MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells.
Lü X; Li H; Xu K; Nesland JM; Suo Z
Histol Histopathol; 2009 Nov; 24(11):1381-90. PubMed ID: 19760587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
